ARTICLE | Financial News
Celldex planning follow-on
February 24, 2012 2:28 AM UTC
Celldex Therapeutics Inc. (NASDAQ:CLDX) proposed a follow-on late Thursday underwritten by Jefferies; Wedbush PacGrow; Oppenheimer; Brean Murray; and Roth. Celldex's rindopepimut is in Phase III testi...